Overview

Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone

Status:
Recruiting
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
This research study is studying a form of radiation therapy called stereotactic body radiation therapy or SBRT as a possible treatment for Cancer that has spread to the spine or other bone
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute